These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 5006481)

  • 1. Enzymatic abnormalities in diseases of sphingolipid metabolism.
    Brady RO
    Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited lipid storage diseases of the central nervous system.
    Percy AK; Shapiro LJ; Kaback MM
    Curr Probl Pediatr; 1979 Sep; 9(11):1-51. PubMed ID: 117977
    [No Abstract]   [Full Text] [Related]  

  • 3. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited neuropathies related to disorders of lipid metabolism.
    Thomas PK
    Adv Neurol; 1988; 48():133-44. PubMed ID: 2446477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent advances in sphingolipidosis research].
    Tamai Y; Kojima H
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic diagnosis of sphingolipidoses.
    Suzuki K
    Methods Enzymol; 1987; 138():727-62. PubMed ID: 2885713
    [No Abstract]   [Full Text] [Related]  

  • 7. Sphingolipidoses.
    Sandhoff K
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():94-105. PubMed ID: 4157247
    [No Abstract]   [Full Text] [Related]  

  • 8. The biochemistry of sphingolipid storage diseases.
    Sandhoff K
    Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
    Gehler J
    Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular bases of lipidoses].
    Tamai Y
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1735-58. PubMed ID: 6442777
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymic diagnosis of sphingolipidoses.
    Suzuki K
    Methods Enzymol; 1978; 50():456-88. PubMed ID: 26837
    [No Abstract]   [Full Text] [Related]  

  • 12. Heritable catabolic and anabolic disorders of lipid metabolism.
    Brady RO
    Metabolism; 1977 Mar; 26(3):329-45. PubMed ID: 13262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzymological approach to the lipidoses.
    Tallman JF; Pentchev PG; Brady RO
    Enzyme; 1974; 18(1):136-49. PubMed ID: 4211795
    [No Abstract]   [Full Text] [Related]  

  • 14. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
    Brady RO; James SP; Barranger JA
    Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibroblast phosphodiesterase deficiency in Niemann-Pick disease.
    Fensom AH; Benson PF; Babarik AW; Grant AR; Jacobs L
    Biochem Biophys Res Commun; 1977 Feb; 74(3):877-83. PubMed ID: 191016
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysosomal storage diseases.
    Glew RH; Basu A; Prence EM; Remaley AT
    Lab Invest; 1985 Sep; 53(3):250-69. PubMed ID: 2993742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipid histochemical studies of lysosomal lipid metabolism diseases].
    Dietzmann K; Mohnike D
    Acta Histochem Suppl; 1984; 30():211-3. PubMed ID: 6201955
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heterogeneity of inborn glycolipidoses and glycoproteinoses and their enzymologic diagnosis].
    Tsvetkova IV
    Vopr Med Khim; 1982; 28(3):32-41. PubMed ID: 6808764
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic and therapeutic applications of sphingolipid hydrolyzing enzymes.
    Brady RO
    Curr Top Cell Regul; 1985; 26():39-50. PubMed ID: 3935381
    [No Abstract]   [Full Text] [Related]  

  • 20. SPECULATIONS ON THE NATURE OF THE METABOLIC DEFECTS IN TAY-SACHS, NIEMANN-PICK, GAUCHER'S AND ALZHEIMER'S DISEASES, AND METACHROMATIC LEUCODYSTROPHY.
    ROUSER G; KRITCHEVSKY G; GALLI C
    J Am Oil Chem Soc; 1965 May; 42():412-6. PubMed ID: 14324332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.